Minerva Surgical Appoints Darin Hammers as New CEO to Lead Expansion in Women's Health Sector

Minerva Surgical, a leader in minimally invasive solutions for women's uterine health, has announced the appointment of Darin Hammers as its new President, Chief Executive Officer, and Member of the Board of Directors. This decision underscores the company's commitment to strengthening its position in the gynecology market, particularly in the treatment of Abnormal Uterine Bleeding (AUB). Hammers brings over three decades of experience in the medical device industry, including leadership roles at EndoGastric Solutions, DYSIS Medical, and Cogentix Medical, as well as significant tenures with C.R. Bard and Boston Scientific Corporation.

Dr. Uri Geiger, Chairman of Minerva Surgical, highlighted Hammers' strategic capabilities and operational effectiveness, expressing confidence in his ability to drive the company's growth and innovation. Hammers' vision for Minerva Surgical focuses on enhancing women's quality of life through advanced medical technologies, with an emphasis on expanding the company's reach in the gynecology market. His leadership is expected to accelerate the development of minimally invasive alternatives to hysterectomy, addressing a critical need in gynecological care.

The appointment of Hammers is poised to have a significant impact on the women's health sector, as Minerva Surgical continues to innovate in the treatment of uterine cavity conditions. The company's product line, designed for use in various medical treatment settings, offers flexibility and accessibility, potentially reshaping treatment paradigms for common gynecological issues. With Hammers at the helm, Minerva Surgical is well-positioned to lead advancements in patient care and treatment options, influencing the broader medical device industry.

For more information about Minerva Surgical's innovative medical devices, visit https://minervasurgical.com/. The company's focus on minimally invasive solutions represents a pivotal trend in gynecological care, one that is expected to grow under Hammers' leadership.